用于溶酶体储存障碍的基因组编辑工具
Esteban Alberto Gonzalez1,2, Helena Nader3, Marina Siebert4,5,6
1Cell, Tissue and Gene Laboratory, Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Advances in experimental medicine and biology
|July 24, 2023
概括
基因组编辑通过实现精确的基因修改,推动了溶酶体疾病的研究和治疗. 这项技术有助于了解疾病机制和开发新型治疗方法,潜在的基因编辑产品接近可用性.
科学领域:
- 生物医学研究的研究.
- 遗传学和基因组学 遗传学和基因组学
- 分子生物学分子生物学
背景情况:
- 基因组编辑允许精确修改DNA序列.
- lysosomal 疾病是一组罕见的遗传疾病.
- 目前对溶酶体疾病的治疗方法有限.
研究的目的:
- 总结基因组编辑在 lysosomal 疾病中的应用.
- 突出基因编辑在疾病发病研究和药物发现中的应用.
- 审查基因编辑作为溶酶体疾病的治疗策略.
主要方法:
- 审查现有的关于在 lysosomal 疾病中的基因组编辑应用的文献.
- 专注于研究为疾病建模开发细胞系的研究.
- 对临床前和临床基因疗法试验的分析.
主要成果:
- 基因组编辑有助于创建疾病模型,用于研究病变发生.
- 它有助于药物发现和理解变种病原性.
- 基因编辑显示出作为治疗溶酶体疾病的治疗平台的前景.
结论:
- 基因组编辑正在迅速改变溶酶体疾病研究的格局.
- 它为开发向治疗提供了新的途径.
- 针对这些疾病的第一个基因编辑产品可能很快就会上市.
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:59CRISPR
52.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.4K